NexgenRx Inc.
NXG.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.44M | 921.30K | 1.03M | 712.50K | 480.30K |
| Total Depreciation and Amortization | 565.60K | 728.50K | 213.30K | 212.90K | 215.00K |
| Total Amortization of Deferred Charges | 257.40K | 146.20K | 691.90K | 691.90K | 691.90K |
| Total Other Non-Cash Items | 565.60K | 568.60K | 560.30K | 537.60K | 565.00K |
| Change in Net Operating Assets | 549.10K | 1.21M | -480.10K | -685.60K | -489.90K |
| Cash from Operations | 3.37M | 3.58M | 2.02M | 1.47M | 1.46M |
| Capital Expenditure | -190.60K | -213.10K | -233.70K | -236.60K | -72.40K |
| Sale of Property, Plant, and Equipment | 23.70K | 23.70K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.80K | -167.30K | -279.80K | -305.10K | -311.30K |
| Cash from Investing | -338.60K | -356.60K | -513.30K | -541.50K | -383.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -101.70K | -110.60K | -127.80K | -125.50K | -115.60K |
| Issuance of Common Stock | -- | -- | 0.00 | 62.50K | 62.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -936.40K | -935.70K | -910.70K | -652.80K | -655.20K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.01M | -1.01M | -1.00M | -696.80K | -692.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.03M | 2.20M | 501.60K | 231.20K | 386.60K |